KAER BIOTHERAPEUTICS CORPORATION
Medtech · Private
Aerosol surfactant replacement therapy for neonatal respiratory distress syndrome, delivered non-invasively via fine particle aerosol to peripheral lungs
- Grants
- $2.6M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $66K
- 1 award · Defense
- #555 of 4531 in medtech
- Patents
- 14
- 6 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2013201420152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · Supraer-ca Model 3 | $65,507 | |
| Federal grant | Department of Health and Human Services · Phase I · Aerosol Delivery of Surfactant for ARDS | $290,883 | |
| Federal grant | Department of Health and Human Services · Phase II · Aerosol Delivery of Surfactant for ARDS | $986,436 | |
| Federal grant | Department of Health and Human Services · Phase I · Non-Invasive Surfactant Aerosol Therapy for RDS | $299,719 | |
| Federal grant | Department of Health and Human Services · Phase II · Aerosol Delivery of Surfactant for ARDS | $976,638 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 552 | EmergenceMed, LLC | $69K | — |
| 553 | PRECISION VISION, INC. | $68K | — |
| 554 | Quantum Surgical Inc | $67K | $68M |
| 555 | KAER BIOTHERAPEUTICS CORPORATION | $66K | — |
| 556 | PLENOPTIKA, INC. | $65K | $50K |
| 557 | PHOTOSOUND TECHNOLOGIES, INC. | $65K | — |
| 558 | DAKTARI DIAGNOSTICS, INC. | $63K | $34M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Ergonomic And Utilitarian Aerosol Delivery Systemapplication
- Aerosol Drug Inspiratory With Respiratory Support Capabilityapplication
- In-line Pressure Balanced Aerosol Concentratorapplication
- Apparatus And Method For Generating Fine Particle Aerosols With Helioxgranted
- Apparatus And Method For Generating Particle Aerosols With Helioxgranted
- Aerosolizing Nozzle And Method Of Operating Such Aerosolizing Nozzlegranted
- Apparatus And Method For Generating And Concentrating Fine Particle Aerosolsapplication
- Apparatus And Method For Generating And Concentrating Fine Particle Aerosolsgranted
- Two-stage Apparatus And Method For Generating And Concentrating Fine Particle Aerosolsgranted
- Aerosolizing Nozzle And Method Of Operating Such Aerosolizing Nozzlegranted
- Apparatus And Method For Generating And Concentrating Fine Particle Aerosolsapplication
- Ergonomic And Utilitarian Aerosol Delivery Systemapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.